Meeting
2023 ASCO Genitourinary Cancers Symposium
Homologous recombination repair (HRR) mutation concordance between liquid biopsy (LB) and tumor tissue by NGS in a real-world prostate cancer (PC) database.
Authors
John Shen
UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA
John Shen , Liang Wang , Ali Raza Khaki , Rafael E Jimenez , Elizabeth Mauer , Melissa Conrad Stoppler , Calvin Y. Chao , Manish Kohli
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 260)
DOI
10.1200/JCO.2023.41.6_suppl.260
Abstract #
260
Poster Bd #
J17
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Homologous recombination repair gene mutation (HRRm) testing patterns and treatment selection from a real-world cohort of patients with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Neal D. Shore
Poster
2023 ASCO Genitourinary Cancers Symposium
Development and validation of a multigenomic liquid biopsy (PROSTest) for prostate cancer detection.
First Author: Irvin Mark Modlin
Poster
2023 ASCO Genitourinary Cancers Symposium
The impact of homologous recombination repair (HRR) gene mutation status on treatment (tx) patterns and clinical outcomes among patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the United States (US).
First Author: Pedro C. Barata
Poster
2022 ASCO Genitourinary Cancers Symposium
DNA damaging therapies in patients (pts) with prostate cancer (PC) and pathogenic alterations in homologous recombination repair (HRR) genes.
First Author: Laura Graham